MATTHEW J BELLIZZI, MD, PHD
Neurology at Elmwood Ave, Rochester, NY

License number
New York 262148
Category
Neurology
Type
Neurology
Address
Address
601 Elmwood Ave, Rochester, NY 14642
Phone
(585) 275-7854
(585) 275-9953 (Fax)

Personal information

See more information about MATTHEW J BELLIZZI at radaris.com
Name
Address
Phone
Matthew Bellizzi
Rochester, NY
(585) 256-1819
Matthew Bellizzi
960 Meigs St, Rochester, NY 14620
(585) 256-1819
Matthew J Bellizzi, age 49
960 Meigs St, Rochester, NY 14620
(585) 256-1819

Professional information

See more information about MATTHEW J BELLIZZI at trustoria.com
Matthew J Bellizzi Photo 1
Dr. Matthew J Bellizzi, Rochester NY - MD (Doctor of Medicine)

Dr. Matthew J Bellizzi, Rochester NY - MD (Doctor of Medicine)

Specialties:
Neuropsychiatry (Neurology)
Address:
Strong Neurology
601 Elmwood Ave SUITE 681, Rochester 14642
(585) 275-1200 (Phone)
University Rchstr Med Cntr Nrgy
601 Elmwood Ave SUITE 673, Rochester 14642
(585) 275-2559 (Phone)
Rochester Multiple Sclerosis Ct
601 Elmwood Ave SUITE 605, Rochester 14642
(585) 275-7854 (Phone)
Certifications:
Neurology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Strong Neurology
601 Elmwood Ave SUITE 681, Rochester 14642
University Rchstr Med Cntr Nrgy
601 Elmwood Ave SUITE 673, Rochester 14642
Rochester Multiple Sclerosis Ct
601 Elmwood Ave SUITE 605, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Education:
Medical School
University of Rochester
Graduated: 2003


Matthew John Bellizzi Photo 2
Matthew John Bellizzi, Rochester NY

Matthew John Bellizzi, Rochester NY

Specialties:
Neurologist
Address:
601 Elmwood Ave, Rochester, NY 14642


Matthew Bellizzi Photo 3
Chemical Preconditioning As A Preventative Or Treatment For Excitotoxic Synaptic Damage

Chemical Preconditioning As A Preventative Or Treatment For Excitotoxic Synaptic Damage

US Patent:
2009022, Sep 3, 2009
Filed:
Oct 30, 2006
Appl. No.:
12/092110
Inventors:
Matthew J. Bellizzi - Rochester NY, US
Shao-Ming Lu - Setauket NY, US
Harris A. Gelbard - Pittsford NY, US
International Classification:
A61K 31/4406, C12Q 1/02, A61P 25/00
US Classification:
514355, 435 29
Abstract:
A method of preventing HIV-1 associated dendritic pathology in a brain cell, comprising contacting the cell with a therapeutically effective dose of a mitochondrial ATP-sensitive potassium channel agonist. A method of preventing HIV-1 associated dendritic pathology in a brain cell, comprising contacting the cell with a therapeutically effective dose of an inhibitor of succinate dehydrogenase. A method of preventing HIV-1 associated dendritic pathology in a brain cell, comprising contacting the cell with a therapeutically effective dose of a stimulator of production of reactive oxygen species. A model for the study of HIV-1 associated dendritic pathology, comprising a) contacting a hippocampal slice with platelet-activating factor; and b) stimulating the hippocampal slice of a) with high frequency stimulation.